GENE ONLINE|News &
Opinion
Blog

.

Зеркало официального сайта всегда доступно для входа на Мостбет, даже при ограничениях. Скачать Mostbet – это шаг к удобству и азартным развлечениям.

Если вы ищете место для увлекательных ставок, обратите внимание на Joycasino, где лучшие предложения для игроков ждут вас.
last added cars
2023-05-03|

Dermatologists Broke the New World Record of Smallest Detected Skin Cancer of 0.65 mm in Size

by Richard Chau
Share To

May is Melanoma and Skin Cancer Awareness Month, and this year, the month began with good news regarding the early diagnosis of skin cancer. A multi-disciplinary team at the Oregon Health and Science University (OHSU) in Portland, Oregon broke the new Guinness World Record of the “Smallest detected skin cancer” by identifying a melanoma lesion that measures 0.65 mm (0.0256 inches) in diameter.

The OHSU team made this record-breaking discovery last year using state-of-the-art, non-invasive imaging technology and they received official certification from a judge from the Guinness World Records on May 1. 

Related article: Targeting Metabolism for Noninvasive Multi-Cancer Early Detection Tests

A Deadly Form of Skin Cancer

Melanoma develops in melanocytes, the skin’s pigment-producing cells. It is a relatively rare but deadly form of skin cancer, which accounts for only about 1% of skin cancers but results in a large majority of skin cancer deaths. Also, its aggressiveness also explains why melanoma can be highly dangerous. Unlike other more common forms of skin cancer such as basal cell and squamous cell carcinomas which rarely spread beyond the original tumor site, melanoma is more likely to invade nearby lymph nodes or tissues and metastasize to other parts of the body.

Melanoma incidence has dramatically increased over the past few decades, which is probably due to rising levels of ultraviolet (UV) exposure. According to estimates made from the National Cancer Institute (NCI)’s Surveillance, Epidemiology, and End Results (SEER) Program, the number of newly diagnosed melanoma cases and people who died from melanoma in the U.S. in 2023 will be 97,610 and 7,990 respectively.

Early Detection Saves Lives

Fortunately, melanoma is considered a highly treatable cancer when detected early. With reference to the figures from the above-mentioned SEER program, compared to a 35.1% 5-year relative survival for patients with distant metastasis, 99.6% of patients with localized melanoma of the skin may survive 5 years after the initial diagnosis.

With the aim of achieving early detection of small, localized skin cancer lesions, the OHSU team, led by dermatologist Dr. Alexander Witkowski, an assistant professor of dermatology at the OHSU School of Medicine, reported a non-invasive combination of imaging and molecular techniques for identifying micro-melanomas (< 2 mm in diameter) in the journal Dermatology Practical & Conceptual in January. 

Dr. Witkowski first captured the image of a tiny suspected skin lesion on the right cheek of a female patient using a smartphone-based dermatoscope. Afterwards, his team performed additional imaging using reflectance confocal microscopy (virtual biopsy), which revealed the presence of atypical cells indicative of melanoma. Subsequent physical biopsy of the mole of concern, melan-A staining and diagnostic 23-gene expression profile (GEP) test by the team confirmed that the lesion was a micro-melanoma in situ measuring 0.65 mm in diameter. 

(A) Clinical image of the patient’s pigmented skin lesion (arrow); (B) Zoomed digital dermoscopy image of the lesion; (C) Reflectance confocal microscopy image showing a micro-melanoma in situ measuring 0.65 mm in diameter. (Source: Dermatology Practical & Conceptual)

The OHSU team’s discovery marked the smallest skin cancer (both invasive or in-situ) ever reported. Dr. Witkowski believed that this achievement would be of paramount importance because the melanoma “was found before it had the opportunity to spread to other parts of the body.”

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Highlights from ESMO 2024: Key Oncology Advances from Major Pharmaceutical Companies
2024-09-19
R&D
Merck’s KEYTRUDA Fails in Early-Stage Lung and Skin Cancer Trials, Ends Two Phase 3 Studies
2024-08-30
ASCO 2024: Covering Skin Cancer, Bispecific Antibody Treatment, TIGIT-Targeted Drugs, Radiotherapy and More
2024-05-29
LATEST
Beyond Pouch Packaging: Hanmi Pharmaceutical Introduces a New Automated Vial Dispensing Solution in Canada and the United States
2025-02-13
NASA Says There’s a 1 in 43 Chance an Asteroid 2024 YR4 Could Hit Earth in 2032—Should We Worry?
2025-02-13
Sodium Channel Targeting: What the Latest FDA Non-Opioid Approval Reveals About the Next Big Thing in Pain Relief
2025-02-12
Novartis Reclaims Abelacimab in $925M Deal to Boost Cardiovascular Portfolio
2025-02-12
GLP-1 Weight Loss Drugs Might Cause Blindness
2025-02-11
South Korea’s Olix Strikes $660M Deal with Eli Lilly for Phase 1 MASH candidate
2025-02-11
22 USA States Sue Trump Administration for Slashing Critical Medical Research Funding
2025-02-11
EVENT
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-04
MIXiii Health-Tech.IL
Jerusalem, Israel
2025-03-05
Medical Japan
Osaka, Japan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
Scroll to Top